Skip to main content
. 2021 May 28;73(7):1155–1166. doi: 10.1002/art.41655

Table 1.

Genetic loci found to be associated with increased HZ risk in the European ancestry GWAS*

Allele Time to HZ event

Incidence of HZ

(case versus control)

Disease, ethnicity Locus Chr

Reference

SNP ID

Position

Reference

allele

Alternative

allele

Alternative

allele

frequency

HR (95% CI) P OR (95% CI) P
RA
European PMEPA1 20 rs59967896 56216698 T TCAA 0.03 3.75 (2.46–5.71) 8.34 × 10−10 4.1 (2.51–6.69) 2.34 × 10−7
PsO
European CD83 6 rs112817503 14292820 C T 0.03 5.74 (3.38–9.77) 1.14 × 10−10 7.71 (4.02–14.8) 6.25 × 10−8
European UGDH 4 rs150665541

39536523

C T 0.03 4.86 (2.79–8.45) 2.10 × 10−8 5.46 (2.88–10.3) 3.57 × 10−6
European VWF 12 rs200638456

6102826

T TAC 0.07 3.5 (2.25–5.46) 2.94 × 10−8 4.04 (2.42–6.75) 1.08 × 10−6
*

GWAS = genome‐wide association study; Chr = chromosome; SNP ID = single‐nucleotide polymorphism cluster identification; HR = hazard ratio; 95% CI = 95% confidence interval; OR = odds ratio; RA = rheumatoid arthritis; PsO = psoriasis.

Results of the Kaplan‐Meier analyses of time to herpes zoster (HZ) event are presented in Supplementary Figure 4 (available on the Arthritis & Rheumatology website at http://onlinelibrary.wiley.com/doi/10.1002/art.41655/abstract).

C‐statistics for the case versus control logistic regression model are presented in Supplementary Table 5 (available on the Arthritis & Rheumatology website at http://onlinelibrary.wiley.com/doi/10.1002/art.41655/abstract).